Announcements Trials

Browse Landscape

Status

Recruiting 4 Not yet recruiting 1 Completed 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neurofibromatoses 1 Neurofibroma, Plexiform 1

Interventions

3-Iodobenzylguanidine 4 ulixertinib 1 mirdametinib 1 carbon-11 methionine 1 Vaccination 1 Proton Pump Inhibitors 1 Methionine 1 Hydrocortisone 1 Eflornithine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × mirdametinib × CNS × Clear all

NCT05028166 2026-05-08

Individual Patient Compassionate Use of Mirdametinib

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Neurofibromatoses, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡